Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
8.94
-0.56 (-5.89%)
At close: Jan 12, 2026, 4:00 PM EST
9.12
+0.18 (2.01%)
After-hours: Jan 12, 2026, 7:31 PM EST
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $84.19 million as of January 12, 2026. Its market cap has decreased by -79.24% in one year.
Market Cap
84.19M
Enterprise Value
26.37M
1-Year Change
-79.24%
Ranking
Category
Stock Price
$8.94
Market Cap Chart
Since November 6, 2023, Korro Bio's market cap has decreased from $123.80M to $84.19M, a decrease of -31.99%. That is a compound annual growth rate of -16.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 89.46M | 18.60% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |